These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3878965)

  • 1. On the role of aging in cancer incidence: an interpretation of the prostate cancer anomaly with implications for routine screening.
    Cohen P; Dix D
    Prostate; 1985; 6(4):437-43. PubMed ID: 3878965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of the four major cancers in South Dakota.
    Clarke J
    S D Med; 2010; Spec No():6-14. PubMed ID: 20397486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of latent prostate cancer from routine screening: comparison with breast cancer screening.
    Benoit RM; Naslund MJ
    Urology; 1995 Oct; 46(4):533-6; discussion 536-7. PubMed ID: 7571223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neighbourhoods matter too: the association between neighbourhood socioeconomic position, population density and breast, prostate and lung cancer incidence in Denmark between 2004 and 2008.
    Meijer M; Bloomfield K; Engholm G
    J Epidemiol Community Health; 2013 Jan; 67(1):6-13. PubMed ID: 22826293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in cancer incidence in Connecticut.
    Polednak AP
    Conn Med; 1997 Apr; 61(4):211-8. PubMed ID: 9149483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographic distribution of prostate cancer incidence in the era of PSA testing, Connecticut, 1984 to 1998.
    Gregorio DI; Kulldorff M; Sheehan TJ; Samociuk H
    Urology; 2004 Jan; 63(1):78-82. PubMed ID: 14751353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of cancer in the United States.
    Cresanta JL
    Prim Care; 1992 Sep; 19(3):419-41. PubMed ID: 1410056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of cancer. Estimates based on the Connecticut Tumor Registry.
    Feldman AR; Kessler L; Myers MH; Naughton MD
    N Engl J Med; 1986 Nov; 315(22):1394-7. PubMed ID: 3773965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Wu GX; Nelson RA; Kim JY; Raz DJ
    Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chances and risks of prevention in elderly people for the three major cancers: breast-, prostate- and colorectal cancers].
    Kolb GF
    Zentralbl Gynakol; 2006 Jun; 128(3):123-8. PubMed ID: 16758377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of prostate, breast and colorectal cancer after skin cancer diagnosis.
    Levi F; Randimbison L; Te VC; Conconi MM; La Vecchia C
    Int J Cancer; 2008 Dec; 123(12):2899-901. PubMed ID: 18770862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary 8-isoprostane levels and occurrence of lung, colorectal, prostate, breast and overall cancer: Results from a large, population-based cohort study with 14 years of follow-up.
    Gào X; Brenner H; Holleczek B; Cuk K; Zhang Y; Anusruti A; Xuan Y; Xu Y; Schöttker B
    Free Radic Biol Med; 2018 Aug; 123():20-26. PubMed ID: 29778463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age- and time-dependent changes in cancer incidence among immigrants to Sweden: colorectal, lung, breast and prostate cancers.
    Mousavi SM; Fallah M; Sundquist K; Hemminki K
    Int J Cancer; 2012 Jul; 131(2):E122-8. PubMed ID: 22052616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the prevalence of cancer in the United States.
    Polednak AP
    Cancer; 1997 Jul; 80(1):136-41. PubMed ID: 9210719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of invasive cancers following squamous cell skin cancer.
    Levi F; Randimbison L; La Vecchia C; Erler G; Te VC
    Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era.
    Konety BR; Bird VY; Deorah S; Dahmoush L
    J Urol; 2005 Nov; 174(5):1785-8; discussion 1788. PubMed ID: 16217287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of increasing detection in the rising incidence of prostate cancer.
    Potosky AL; Miller BA; Albertsen PC; Kramer BS
    JAMA; 1995 Feb; 273(7):548-52. PubMed ID: 7530782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening.
    Humphrey PA; Keetch DW; Smith DS; Shepherd DL; Catalona WJ
    J Urol; 1996 Mar; 155(3):816-20. PubMed ID: 8583583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer in Canada: Stage at diagnosis.
    Bryan S; Masoud H; Weir HK; Woods R; Lockwood G; Smith L; Brierley J; Gospodarowicz M; Badets N
    Health Rep; 2018 Dec; 29(12):21-25. PubMed ID: 30566206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of trends in age-adjusted incidence rates for 10 major sites of cancer.
    Sullivan PD; Christine B; Connelly R; Barrett H
    Am J Public Health; 1972 Aug; 62(8):1065-71. PubMed ID: 5046446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.